Exclusive

Publication

Byline

Border tensions with Pak open $200 mn pharma window for India in Afghanistan

New Delhi, Jan. 12 -- Afghanistan's border tensions with Pakistan, which led to the shutdown of vital transit routes, may have opened up a $200 million pharmaceutical opportunity for India. India is ... Read More


States crack down on Almont-Kid syrup after lab finds deadly ethylene glycol

New Delhi, Jan. 12 -- State drug regulators in India have launched a massive crackdown and issued urgent public health alerts to stop the use of paediatric cough syrup Almont-Kid after samples from a ... Read More


As essential antibiotics fail, regulator mulls R&D push, curbs on misuse

New Delhi, Jan. 9 -- With antimicrobial resistance now a major public health and economic threat, India's top drug regulator is rolling out an overhaul on the development, sale and strict monitoring o... Read More


As essential antibiotics fail, regulator mulls R&D push, curbs on misuse

New Delhi, Jan. 9 -- With antimicrobial resistance now a major public health and economic threat, India's top drug regulator is rolling out an overhaul on the development, sale and strict monitoring o... Read More


India plans new bulk drug licence regime, supplier database to fix accountability

New Delhi, Jan. 6 -- Facing mounting scrutiny over drug safety lapses, India is preparing an overhaul of its pharmaceutical licensing framework by introducing a separate wholesale licensing regime for... Read More


India to introduce new regime to track bulk drug products

new delhi, Jan. 6 -- Facing mounting scrutiny over drug safety lapses, India is working to overhaul its pharmaceutical licensing framework by introducing a separate wholesale licensing regime for bulk... Read More


New drug regime to track bulk products in offing

new delhi, Jan. 6 -- Facing mounting scrutiny over drug safety lapses, India is working to overhaul its pharmaceutical licensing framework by introducing a separate wholesale licensing regime for bulk... Read More


Govt considers lifeline for MSME drug firms

New Delhi, Dec. 30 -- With thousands of small drug manufacturers struggling to meet tougher quality norms, the government is weighing a year's extension to the deadline for complying with the revised ... Read More


Govt considers lifeline for MSME drug firms

New Delhi, Dec. 29 -- With thousands of small drug manufacturers struggling to meet tougher quality norms, the government is weighing a year's extension to the deadline for complying with the revised ... Read More


Govt considers lifeline for MSME drug firms

New Delhi, Dec. 29 -- With thousands of small drug manufacturers struggling to meet tougher quality norms, the government is weighing a year's extension to the deadline for complying with the revised ... Read More